Damora Therapeutics's total assets for Q4 2025 were $260.53M, an increase of 854.42% from the previous quarter. DMRA total liabilities were $20.15M for the fiscal quarter, a 443.19% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.